INDIA AND CII SUPPORT AETHLON HIV/HEPATITIS TRIALS.Aethlon Medical, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :AEMD AEMD Automotive Electric Motor Drive (US Department of Energy program) ), San Diego, has been advised by Qualtran LLC, a contract research organization (CRO) managing clinical trials for Aethlon in India, that both the Government of India The Government of India (Hindi: भारत सरकार [3]Bhārat Sarkār), officially referred to as the Union Government, and commonly as Central Government and the Confederartion of Indian Industry (CII) are supportive of Aethlon's upcoming HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. and Hepatitis-C trials. Sandeep Malik, president of Qualtran, stated, "We are pleased to disclose that Aethlon has received letters of support from both the Government of India and the Confederation of Indian Industry The Confederation of Indian Industry (CII) is a non-government, not-for-profit, industry-led and industry-managed organisation, playing a proactive role in India’s development process. which is India's premier business association." Malik continued, "Members of Parliament, Ashok Argal and Shripad Naik are personally supportive of Aethlon's HIV trials in India. They believe that if successful, Aethlon's technology could have a profound impact on the condition of HIV patients in India and around the world." Malik concluded, "HIV infections in India could increase sharply if effective treatment strategies are not widely implemented. This could have devastating effects on the country's economic and social systems. Aethlon's Hemopurifier(TM) technology and forthcoming trials have been very well received by key opinion leaders in India." According to the Gates Foundation, 5.1 million individuals in India were infected with HIV in 2004, a ten-fold increase over the last decade. It is projected that the number of HIV-infected citizens in India could increase to 20-25 million by 2010. Aethlon stated that site selection for the trials is under way, and that patient enrollment should begin in the coming months. About Aethlon Medical Aethlon Medical is pioneering the development of viral filtration devices to treat HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , Hepatitis-C (HCV HCV abbr. hepatitis C virus HCV 1 Hepatitis C virus, see there 2. Human coronavirus. See Coronavirus. ), and pathogens that are mass casualty biological warfare candidates. Each treatment application employs the use of a proprietary technology known as the Hemopurifier(TM), which is designed to rapidly reduce the presence of infectious disease and toxins in the body. The Hemopurifier converges the established scientific principals of affinity chromatography and hemodialysis as a means to augment the immune response of clearing viruses and toxins from the blood before cell and organ infection can occur. For more information, visit http://www.aethlonmedical.com or call 858/459-7800 ext. 300. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion